Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedicle-based access system that provides direct visualization of anatomical landmarks; Sigma PTP Access and Patient Positioning System; squadron lateral retractor designed to maximize patient outcomes; Invictus Spinal Fixation System, a thoracolumbar fixation system to treat a range of pathologies; and Invictus MIS SingleStep System that provides minimally invasive pedicle screw placement Please visit their website for more information.
*Proprietary Buy Sell Volume Indicator
| Revenue: $151M |
| Revenue Growth (YOY): 27.44% |
| Profit (% of Rev): 68.16% |
| Income (% of Rev): -26.28% |
| Income Growth (YOY): -7.12% |
| Operating Income: $-31M |
| Operating Cash Flow: $-5M |
| Operating Cash Flow Growth (YoY): -69.09% |
| Annual Dividend Yield: 0.00% |
| Total Assets: $746M |
| Total Liabilities: $747M |
| Cash & Equivalent: $81M |
| Total Debt: $564M |
| Debt/Equity: -392.59 |
| Quick Ratio: 1.15 |
| Current Ratio: 2.32 |
| Price/Book: -585.77 |
| Price/Earnings: -5.03 |
| EBITDA: $-11M |
| EPS: -0.28 |
Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering all the above parameters, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Buy.
TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.
Contact @ support@theoryofstocks.com
© 2024 Stock Articles. All rights reserved.